Matinas BioPharma
MTNB
MTNB
22 hedge funds and large institutions have $194K invested in Matinas BioPharma in 2024 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 1 increasing their positions, 7 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
90% less capital invested
Capital invested by funds: $1.97M → $194K (-$1.78M)
Holders
22
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$12.1K | |
| 2 | +$9.27K | |
| 3 | +$4.53K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$562 |
| 5 |
NA
NewEdge Advisors
New Orleans,
Louisiana
|
+$1 |
Top Sellers
| 1 | -$457K | |
| 2 | -$72.9K | |
| 3 | -$72K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$40.7K |
| 5 |
SIG
Sargent Investment Group
Bethesda,
Maryland
|
-$9.59K |